Stock data

青松健康 (6931)

青松健康 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$110.90M, up 10.9% from a year earlier. EPS over the last four quarters totals NT$3.76.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 青松健康 in Insightr